Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 27, 2014	Sep. 28, 2013	Sep. 29, 2012
Cash flows from operating activities:
Net income (loss)	$ 9,821	$ (900)	$ 22,113
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	35,781	32,968	30,425
Stock-based compensation	7,678	15,892	7,510
Excess tax benefits from stock-based awards	(498)	(388)	(1,881)
Deferred income taxes	5,548	(3,233)	14,411
Gain on sale of property and equipment	(4,875)	0	0
Loss on disposal of property, plant and equipment	1,063	547	180
Write-off of deferred financing costs	1,731	0	0
Other long-lived asset impairments	5,870	0	0
Unrealized (gains) losses on derivative financial instruments	0	0	(83)
Goodwill impairment	0	7,709	0
Other	249	370	0
Changes in assets and liabilities (excluding businesses acquired):
Receivables	2,655	8,185	(6,841)
Inventories	69,698	(61,697)	(164)
Prepaid expenses and other assets	1,931	4,798	7,549
Accounts payable	(16,321)	(23,866)	9,805
Accrued expenses	8,442	(7,781)	4,955
Other long-term obligations	(2,306)	(886)	1,190
Net cash provided (used) by operating activities	126,467	(28,282)	89,169
Cash flows from investing activities:
Additions to property, plant and equipment	(17,173)	(25,172)	(39,592)
Businesses acquired, net of cash acquired	(20,282)	(4,835)	0
Proceeds from disposals of land, buildings, etc.	8,737	0	0
Change in restricted cash and cash equivalents.	(14,283)	0	0
Maturities of short-term investments.	17,820	4,885	0
Investment in short-term investments	(10,000)	0	(4,885)
Net cash (used) provided by investing activities	(35,181)	(25,122)	(44,477)
Cash flows from financing activities:
Repayments on revolving line of credit	(301,000)	(368,000)	(339,000)
Borrowings on revolving line of credit	278,000	391,000	304,000
Repayments of long-term debt	(367)	(332)	(353)
Issuance of long-term debt	0	0	49,312
Proceeds from issuance of common stock	1,165	613	2,129
Excess tax benefits from stock-based awards	498	388	1,881
Repurchase of common stock, including shares surrendered for tax withholding	(2,332)	(2,731)	(24,829)
Distribution to noncontrolling interest	(633)	(629)	0
Payment of financing costs	(3,090)	0	(1,715)
Net cash provided (used) by financing activities	(27,759)	20,309	(8,575)
Effect of exchange rate changes on cash and equivalents	(7)	(224)	327
Net (decrease) increase in cash and cash equivalents	63,520	(33,319)	36,444
Cash and cash equivalents at beginning of year	15,156	48,475	12,031
Cash and cash equivalents at end of year	78,676	15,156	48,475
Supplemental information:
Cash paid for interest	41,549	42,960	40,930
Cash paid for income taxes - net of refunds	826	(2,493)	(8,048)
Non-cash investing and financing activities:
Capital expenditures incurred but not paid	238	926	1,677
Liability for contingent performance based payments	249	4,165	0
Restricted share stock bonus	$ 4,086	$ 9,579	$ 948